The global chronic hepatitis B treatment market is undergoing significant development. This movement can be attributed to a number of factors, including an aging population, advanced diagnostic capabilities, and growing awareness about the disease. The market is in addition driven by developments in treatment approaches, such as antiviral drugs. A… Read More